View Full Version : Alert. Strontium Blood Clot Risk Confirmed By New Study

03-26-12, 06:22 AM
Vivian Goldschmidt, MA
March 26, 2012

It made big news abroad, especially in Europe. But chances are that if you live in the United States, you didn’t hear about this at all. And it might make you wonder about the well-known saying, that “bad news travels fast”.
The latest osteoporosis drug fiasco is about the drug Protelos, the trademarked name for strontium ranelate, which is not sold in the U.S. and is also marketed under the names Bivalos, Osseor, Ossum, Protos, and Protaxos.
According to an article published this week in The Telegraph,

“Doctors ‘should not prescribe’ strontium ranelate – sold in Britain under the brand name Protelos – to patients who either have venous thromboembolism (VTE), or have a history of the condition, the European Medicines Agency (EMA) has warned. Physicians should also refrain from prescribing it to patients ‘who are temporarily or permanently immobilized’”.


03-26-12, 06:28 AM
I was presribed Protos, but only took it for a while, because it was loaded with aspartame. I took strontium citrate for two years, until I read, probably on this same site, about adverse effects. Didn't seem to help anyway.

03-26-12, 01:12 PM
I found this site about strontium. Thought I'd pass it on.